Advertisement

Topics

bluebird bio, Inc. Company Profile

18:15 EDT 22nd March 2019 | BioPortfolio

bluebird bio is developing innovative gene therapies for severe genetic disorders. At the heart of bluebird bio’s product creation efforts is its broadly applicable gene therapy platform for the development of novel treatments for diseases with few or no clinical options. The company’s novel approach uses stem cells harvested from the patient’s bone marrow into which a healthy version of the disease causing gene is inserted. After being grown in culture, those cells are given back to the patient. bluebird bio’s approach represents a true paradigm shift in the treatment of severe genetic diseases by eliminating the potential complications associated with donor cell transplantation and potentially presenting a one-time transformative therapy. bluebird bio has two later stage clinical products in development for childhood cerebral adrenoleukodystrophy (CCALD) and beta-thalassemia/sickle cell anemia. Led by a world-class team, bluebird bio is privately held and backed by top-tier life sciences investors, including Third Rock Ventures, TVM Capital, Forbion Capital Partners, Easton Capital and Genzyme Ventures. Its operations are located in Cambridge, Mass. and Paris, France. For more information, please visit www.bluebirdbio.com.


News Articles [97 Associated News Articles listed on BioPortfolio]

BlueBird Intersects 1.33% Ni, 1.26% Cu and 0.10% Co over 4. ...

VANCOUVER, Nov. 29, 2018 /PRNewswire/ - BlueBird Battery Metals Inc. (TSXV: BATT; US: BBBMF) (the "Company" or "BlueBird") is pleased to announce results from the Read more...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE

NEW YORK, Dec. 5, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE). Such investors are advised t...

bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility

bluebird bio (NASDAQ:BLUE) has announced the opening of its first wholly owned manufacturing facility in Durham, North Carolina, which will produce lentiviral vector for its investigational gene and c...

ASH18: Bluebird's follow-on CAR-T finds initial success, but durability will be key test

Phase 1 data on a dozen patients hint that bb21217 may deliver the efficacy and persistence that Bluebird and partner Celgene have been vying for.

Wo wird bluebird bio in 5 Jahren sein?

bluebird bio (WKN:A1W025) hatte ein hartes Jahr 2018. Das Unternehmen hat jedoch immer noch eine Marktkapitalisierung von 6,5 Mrd. US-Dollar, obwohl es keine Medikamente auf dem Markt hat. Um diese...

bluebird bio Opens Gene and Cell Therapy Mfg. Facility

NC's Gov. Cooper to cut ribbon on facility that will strengthen bluebird's capabilities to make products for clinical devt. and commercial supply

Bluebird Bio, Inhibrx enter licensing agreement for CAR-T therapies

A licensing deal has been completed between Bluebird Bio and Inhibrx that will focus on research, development and commerciali -More- 

Bluebird Bio, Celgene say enrollment done for CAR-T candidate trial

Enrollment is completed for the midstage trial by Bluebird Bio and partner Celgene to evaluate the experimental chimeric anti -More- 

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Regeneron buys into CAR-Ts with Bluebird Bio deal.

Co-infections, genetic, and antigenic relatedness of avian influenza H5N8 and H5N1 viruses in domestic and wild birds in Egypt.

A total of 50 poultry farms of commercial broilers (N = 39) and commercial layers (N = 11) suffered from respiratory problems and mortality during the period from January 2016 to December 2017 were in...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Long-term Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy

This is a multi-center, long-term safety and efficacy follow-up study for subjects with hemoglobinopathies (β-thalassemia or severe sickle cell disease) who have been treated with ex vivo...

Companies [4 Associated Companies listed on BioPortfolio]

bluebird bio, Inc. bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting

bluebird bio, Inc.

bluebird bio is developing innovative gene therapies for severe genetic disorders. At the heart of bluebird bio’s product creation efforts is its broadly applicable gen...

bluebird bio, Inc. 

REVOLUTION Medicines

The REVOLUTION Medicines team brings deep expertise and a track record of building exceptional life sciences companies. In addition to Dr. Goldsmith, founding president and...

More Information about "bluebird bio, Inc." on BioPortfolio

We have published hundreds of bluebird bio, Inc. news stories on BioPortfolio along with dozens of bluebird bio, Inc. Clinical Trials and PubMed Articles about bluebird bio, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of bluebird bio, Inc. Companies in our database. You can also find out about relevant bluebird bio, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...


Corporate Database Quicklinks



Searches Linking to this Company Record